BioHarvest Sciences Inc. - Form 6-K Filing

This report details BioHarvest Sciences Inc.'s unaudited interim condensed consolidated financial statements for the three and six months ended June 30, 2026. The company operates with a going concern basis, acknowledging a history of operating losses and the need for potential future financing. Key financial highlights include revenues of $17,344 for the six-month period and a net loss of $6,356. The company operates through two business units: Products (nutraceuticals) and CDMO Services. The Products unit focuses on health and wellness solutions, with VINIA® sales reaching cumulative figures of nearly $100 million since its US launch in May 2021. The CDMO unit provides manufacturing services for plant-based active molecules. The report also notes the impact of geopolitical events in Israel and outlines new accounting policies regarding government grants. Subsequent events include advance payments received for R&D support programs.